ImmunityBio Inc
ImmunityBio Inc (IBRX) Straddle
IBRX straddle scan found 109 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 61.7%.
Read more
Trading a IBRX straddle lets you take a pure volatility position on ImmunityBio Inc without committing to a direction. ImmunityBio Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate IBRX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on IBRX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when ImmunityBio Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the IBRX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co.
Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the IBRX straddle is the cleanest expression of that view. Our scanner prices every IBRX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a IBRX straddle into a catalyst or short a IBRX straddle to harvest decay, the options straddle setups that matter are all in one place.
| Jan 21, 2028 | 22.00 | $15.88 | 494 | 23% | 61.7% | $37.88 | $6.13 | 55 |
| Jan 21, 2028 | 20.00 | $14.30 | 494 | 23% | 59.8% | $34.30 | $5.70 | 37 |
| Jan 21, 2028 | 15.00 | $10.10 | 494 | 23% | 57.3% | $25.10 | $4.90 | 675 |
| Sep 25, 2026 | 8.50 | $0.80 | 11 | 23% | 57.0% | $9.30 | $7.70 | 19 |
| Mar 17, 2028 | 12.00 | $7.95 | 550 | 23% | 56.3% | $19.95 | $4.05 | 0 |
| Jan 21, 2028 | 12.00 | $7.70 | 494 | 23% | 56.0% | $19.70 | $4.30 | 22 |
| Jan 19, 2029 | 15.00 | $12.00 | 858 | 23% | 55.3% | $27.00 | $3.00 | 0 |
| Jan 21, 2028 | 17.00 | $12.53 | 494 | 23% | 52.4% | $29.53 | $4.48 | 0 |
| Jan 15, 2027 | 22.00 | $14.53 | 123 | 23% | 52.0% | $36.53 | $7.48 | 14 |
| Apr 16, 2027 | 15.00 | $8.65 | 214 | 23% | 51.9% | $23.65 | $6.35 | 0 |
As of September 15, 2026
Find the right straddle before volatility moves
Track IBRX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→